Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology

The Diagnosis: Genetic Tests and Brain Scans

At a Glance

Miller-Dieker syndrome is diagnosed using an MRI to identify a smooth brain surface (lissencephaly) and genetic tests like a Chromosomal Microarray or FISH. These tests look for a missing piece of DNA on chromosome 17, known as a 17p13.3 microdeletion, which confirms the diagnosis.

The diagnostic journey for Miller-Dieker Syndrome (MDS) often involves two distinct types of “pictures”: a picture of the brain’s structure and a picture of the body’s genetic instructions. Understanding how to read these results is a vital step in advocating for your child’s care.

Brain Imaging: Visualizing the “Smooth Brain”

The first piece of the puzzle is usually an MRI (Magnetic Resonance Imaging). Unlike an X-ray, an MRI uses magnets to create a detailed map of the brain’s surface.

In MDS, doctors are looking for signs of the lissencephaly spectrum [1]:

  • Agyria: Areas where the brain surface is completely smooth, with no folds (gyri) [2].
  • Pachygyria: Areas where the folds are unusually broad and few in number [2].
  • Cortical Thickening: The outer layer of the brain (the cortex) often appears thicker than normal because the neurons didn’t migrate to their proper thin layers [1].

Radiologists may use a “grading” system from 1 (most severe, totally smooth) to 6 (mildest) to describe the extent of these findings [3].

Genetic Testing: Mapping the Deletion

Once lissencephaly is seen on an MRI, genetic testing is used to find the specific cause. There are two primary tools used for MDS:

  1. Chromosomal Microarray (CMA): Think of this as a high-resolution scanner that looks for “missing” or “extra” pieces of genetic code [4]. It is the most common tool used to find the 17p13.3 microdeletion [5].
  2. FISH (Fluorescence In Situ Hybridization): This is a targeted test where scientists use “glowing” markers to see if a specific gene—like PAFAH1B1—is present or missing on the chromosome [6].

Reading the Genetic Report

Genetic reports can look like a different language. Here is a guide to the common terms you may see:

  • 17p13.3 microdeletion: This confirms that a small piece of the “p” arm (short arm) of chromosome 17 at position 13.3 is missing [7].
  • arr [hg19] or [hg38]: “arr” stands for array (the test used). The numbers in brackets refer to the “version” of the human genome map the lab used for comparison [8].
  • del: Short for “deletion,” meaning genetic material is missing.
  • Copy Number Loss: Another way of saying a deletion has occurred (normally, we have two “copies” of every gene; “loss” means only one is left).

Your Genetic Report Checklist

Ensure your child’s report includes the following details:

  • [ ] The exact chromosomal coordinates (the “start” and “stop” points of the deletion).
  • [ ] A list of specific genes included in the deleted section (e.g., PAFAH1B1, YWHAE, CRK).
  • [ ] Whether the finding is classified as “Pathogenic” (meaning it is known to cause the syndrome).

Testing for Parents: The “Balanced Translocation”

In about 80% of MDS cases, the deletion is de novo, meaning it happened by chance and isn’t something the parents carry.

However, in about 20% of cases, a parent may have a balanced translocation. This means all their genetic material is present, but two pieces of chromosomes have “swapped” places. The parent is healthy because they aren’t missing any information, but they have a higher risk of passing on an “unbalanced” set (where information is missing) to future children [9].

Because interpreting recurrence risk is incredibly complex and emotionally fraught, we strongly recommend asking your care team for a referral to a certified Genetic Counselor. They can help you navigate testing (often a karyotype or FISH) and explain the risks for future pregnancies in clear, supportive language [10][11].

Common questions in this guide

What does an MRI show for Miller-Dieker syndrome?
An MRI for Miller-Dieker syndrome typically reveals lissencephaly, meaning the brain surface is unusually smooth. Radiologists look for specific signs like agyria (no folds), pachygyria (broad folds), and a thickened outer layer of the brain.
What is a 17p13.3 microdeletion?
A 17p13.3 microdeletion means a very small piece of genetic material is missing from the short arm of chromosome 17. This specific genetic deletion includes the PAFAH1B1 gene and is the primary cause of Miller-Dieker syndrome.
How is Miller-Dieker syndrome genetically confirmed?
Doctors typically use a Chromosomal Microarray (CMA) or targeted FISH testing to confirm the diagnosis. These tests act like high-resolution scanners to detect the missing genetic material and specific genes absent on chromosome 17.
Do parents need genetic testing if their child has Miller-Dieker syndrome?
Yes, parents are often offered genetic testing because about 20% of cases are linked to a balanced translocation in a parent's chromosomes. A genetic counselor can help arrange a karyotype or FISH test to determine if parents carry this risk factor.
What does "de novo" mean on my child's genetic report?
When a genetic report says a deletion is de novo, it means the genetic change happened spontaneously by chance during early development. It confirms that the missing genetic material was not inherited from either parent's DNA.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you explain the specific genomic coordinates (start and end points) of my child's deletion and what genes are involved?
  2. 2.What 'grade' of lissencephaly was noted on the MRI, and what does that mean for my child's development?
  3. 3.Was this deletion confirmed as 'de novo,' or do we still need to rule out a balanced translocation in the parents?
  4. 4.Does the genetic report use the hg19 or hg38 reference genome?
  5. 5.Are there any other variants of uncertain significance (VUS) on the report we should be aware of?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Lissencephaly with Congenital Hypothyroidism: A Case Report.

    Sahani SK, Pathak A, Nepali B, Rai N

    JNMA; journal of the Nepal Medical Association 2022; (60(255)):978-981 doi:10.31729/jnma.7893.

    PMID: 36705174
  2. 2

    Lissencephaly: Update on diagnostics and clinical management.

    Koenig M, Dobyns WB, Di Donato N

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2021; (35()):147-152 doi:10.1016/j.ejpn.2021.09.013.

    PMID: 34731701
  3. 3

    Electrographic pattern recognition: A simple tool to predict clinical outcome in children with lissencephaly.

    Jauhari P, Farmania R, Chakrabarty B, et al.

    Seizure 2020; (83()):175-180 doi:10.1016/j.seizure.2020.10.020.

    PMID: 33161247
  4. 4

    Experiences in microarray-based evaluation of developmental disabilities and congenital anomalies.

    Ozyilmaz B, Kirbiyik O, Koc A, et al.

    Clinical genetics 2017; (92(4)):372-379 doi:10.1111/cge.12978.

    PMID: 28128450
  5. 5

    D-karyo-A New Prenatal Rapid Screening Test Detecting Submicroscopic CNVs and Mosaicism.

    Shimokawa O, Takeda M, Ohashi H, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(2)) doi:10.3390/diagnostics11020337.

    PMID: 33670620
  6. 6

    Inverted duplication, triplication and quintuplication through sequential breakage-fusion-bridge events induced by a terminal deletion at 5p in a case of spontaneous abortion.

    Chai H, Grommisch B, DiAdamo A, et al.

    Molecular genetics & genomic medicine 2019; (7(10)):e00965 doi:10.1002/mgg3.965.

    PMID: 31478360
  7. 7

    Miller-Dieker Syndrome with unbalanced translocation 45, X, psu dic(17;Y)(p13;p11.32) detected by fluorescence in situ hybridization and G-banding analysis using high resolution banding technique.

    Mishima T, Watari M, Iwaki Y, et al.

    Congenital anomalies 2017; (57(2)):61-63 doi:10.1111/cga.12193.

    PMID: 27644460
  8. 8

    Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview.

    Zahid MF, Malik UA, Sohail M, et al.

    International journal of hematology-oncology and stem cell research 2017; (11(3)):231-239.

    PMID: 28989590
  9. 9

    [Analysis of chromosomes of embryos derived from translocation carriers during preimplantation genetic diagnosis cycles].

    Huang Q, Lin C, Chen Z, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2018; (35(6)):875-878 doi:10.3760/cma.j.issn.1003-9406.2018.06.024.

    PMID: 30512168
  10. 10

    Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.

    Qin Y, Zhang H, Feng L, et al.

    Annals of medicine 2022; (54(1)):2627-2636 doi:10.1080/07853890.2022.2125173.

    PMID: 36148999
  11. 11

    Six families with balanced chromosome translocation associated with reproductive risks in Hainan Province: Case reports and review of the literature.

    Chen YC, Huang XN, Kong CY, Hu JD

    World journal of clinical cases 2020; (8(1)):222-233 doi:10.12998/wjcc.v8.i1.222.

    PMID: 31970191

This page explains Miller-Dieker syndrome diagnostic tests for educational purposes only. Always consult a genetic counselor or pediatric neurologist to interpret your child's specific MRI and genetic reports.

Get notified when new evidence is published on Miller-Dieker syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.